<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753753</url>
  </required_header>
  <id_info>
    <org_study_id>VERIfynow FRENCH registrY</org_study_id>
    <secondary_id>CPP n°2008-N2</secondary_id>
    <secondary_id>AFFSAPS 2008-A00411-54</secondary_id>
    <nct_id>NCT00753753</nct_id>
  </id_info>
  <brief_title>VerifyNow French Registry</brief_title>
  <acronym>VERIFRENCHY</acronym>
  <official_title>Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Pour le Développement des Soins Cardiologiques de la ville de Chartres</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Association Pour le Développement des Soins Cardiologiques de la ville de Chartres</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of clopidogrel or aspirin reactivity as
      measured by a point-of-care platelet function assay on thrombotic or bleeding events after
      percutaneous coronary intervention (PCI) with drug eluting or bare metal stent.

      Methods:

      Platelet reactivity on clopidogrel and aspirin therapy is measured before PCI with VerifyNow
      (Accumetrics Inc.,San Diego, CA, USA) P2Y12 or aspirin assay respectively in 1000 consecutive
      patients from 20 centers in France undergoing coronary angioplasty with stent.

      Exclusion criteria are:

      Acute myocardial infarction, treatment with vitamin K antagonists and the use of antiGP2b3a
      before PCI. All patients are pre-treated with clopidogrel and aspirin. Non-response to
      aspirin or clopidogrel is determined according to the result of the VerifyNow assay (cut off
      : &lt; 15 % for P2Y12 and &gt; 550 ARU for aspirin). The primary end point is the occurrence of
      definite or probable stent thrombosis (ARC definition) and the secondary end-points include
      global and cardio-vascular mortality, non fatal myocardial infarction and major bleeding. A
      clinical evaluation is scheduled at discharge and by telephone contact at one month and one
      year.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality, cardio-vascular mortality, non fatal Myocardial infarction, urgent coronary revascularisation , re-hospitalization, severe bleeding</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1001</enrollment>
  <condition>Stent Thrombosis</condition>
  <condition>Clopidogrel</condition>
  <condition>Aspirin</condition>
  <condition>Bleeding</condition>
  <condition>Angioplasty</condition>
  <eligibility>
    <study_pop>
      <textblock>
        real world patient referred for coronary angioplasty with stent
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Coronary angioplasty with stent

        Exclusion Criteria:

          -  Use of AGP2b3a

          -  Acute myocardial infarction

          -  No aspirin and clopidogrel pretreatment

          -  Use of AVK

          -  Aspirin or clopidogrel contre-indication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>gregoire rangé</last_name>
    <role>Principal Investigator</role>
    <affiliation>GACI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>cardiology unit / Les hopitaux de Chartres</name>
      <address>
        <city>Chartres</city>
        <state>Eure Et Loir</state>
        <zip>28000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2008</study_first_submitted>
  <study_first_submitted_qc>September 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2008</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association Pour le Développement des Soins Cardiologiques de la ville de Chartres</investigator_affiliation>
    <investigator_full_name>RANGE Gregoire</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>stent thrombosis</keyword>
  <keyword>clopidogrel</keyword>
  <keyword>aspirin</keyword>
  <keyword>bleeding</keyword>
  <keyword>coronary</keyword>
  <keyword>angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

